Gro O. Eilertsen

Tromso, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Sámi psoriatic arthritis patients in northern Norway receive less conventional synthetic disease-modifying anti-rheumatic drug treatment and have more arthritis, axial symptoms, and joint damage.

Sámi psoriatic arthritis patients in northern Norway receive less conventional synthetic disease-modifying anti-rheumatic drug treatment and have more arthritis, axial symptoms, and joint damage.

Journal: Scandinavian journal of rheumatology

Published: July 03, 2026

Sami patients in northern Norway experience longer symptoms duration before psoriatic arthritis diagnosis and have more axial involvement.

Sami patients in northern Norway experience longer symptoms duration before psoriatic arthritis diagnosis and have more axial involvement.

Journal: Rheumatology advances in practice

Published: May 12, 2025

Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus.

Smoking associates with increased BAFF and decreased interferon-γ levels in patients with systemic lupus erythematosus.

Journal: Lupus science & medicine

Published: July 14, 2021

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.

Journal: PloS one

Published: July 13, 2021

Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.

Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.

Journal: PloS one

Published: March 18, 2021

The Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus.

The Impact of Cytokines on the Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus.

Journal: Journal of clinical medicine

Published: May 21, 2019

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.

Hypocomplementemia as a Risk Factor for Organ Damage Accrual in Patients with Systemic Lupus Erythematosus.

Journal: Journal of immunology research

Published: September 24, 2018

Association of Achieving Lupus Low Disease Activity State Fifty Percent of the Time With Both Reduced Damage Accrual and Mortality in Patients With Systemic Lupus Erythematosus.

Association of Achieving Lupus Low Disease Activity State Fifty Percent of the Time With Both Reduced Damage Accrual and Mortality in Patients With Systemic Lupus Erythematosus.

Journal: Arthritis care & research

Published: August 15, 2018

Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.

Principal component analysis reveals disconnect between regulatory cytokines and disease activity in Systemic Lupus Erythematosus.

Journal: Cytokine

Published: May 29, 2018

Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis.

Mesenchymal stem cells and T cells in the formation of Tertiary Lymphoid Structures in Lupus Nephritis.

Journal: Scientific reports

Published: January 23, 2018

Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression.

Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression.

Journal: The journal of pathology. Clinical research

Published: June 19, 2017

Dermatological moulage collections in the Nordic countries.

Dermatological moulage collections in the Nordic countries.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: April 27, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026